Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Heimberger, Amy
Professor
Bio
I am a physician-scientist and a board-certified Neurosurgeon with extensive training and experience in the field of immunology. My laboratory is focused on elucidating the mechanisms of tumor-mediate... [more]
Horbinski, Craig
Professor
Bio
My career as a physician-scientist and investigative neuropathologist allows me to conduct research that will enhance our understanding of how key driver mutations, like mutant IDH1, affect glioma bio... [more]
Horiuchi, Dai
Assistant Professor
Bio
Our research aims to identify and validate novel therapeutic strategies to significantly lower the mortality rates associated with triple-negative breast cancer (TNBC), which represents one ... [more]
Hussain, Maha H
Professor
Bio
My research is focused on novel therapeutic interventions and I have extensive experience in the design and conduct of clinical trials including federally sponsored multicenter investigator initiated ... [more]